Wall Street brokerages expect Cross Country Healthcare, Inc. (NASDAQ:CCRN) to report $0.06 earnings per share (EPS) for the current fiscal quarter, Zacks Investment Research reports. Four analysts have issued estimates for Cross Country Healthcare’s earnings. The lowest EPS estimate is $0.05 and the highest is $0.06. Cross Country Healthcare posted earnings of $0.16 per share in the same quarter last year, which would indicate a negative year over year growth rate of 62.5%. The business is scheduled to announce its next quarterly earnings results on Wednesday, August 1st.
According to Zacks, analysts expect that Cross Country Healthcare will report full-year earnings of $0.45 per share for the current year, with EPS estimates ranging from $0.40 to $0.50. For the next year, analysts anticipate that the business will report earnings of $0.64 per share, with EPS estimates ranging from $0.53 to $0.71. Zacks’ earnings per share averages are a mean average based on a survey of sell-side research analysts that cover Cross Country Healthcare.
Cross Country Healthcare (NASDAQ:CCRN) last released its quarterly earnings results on Wednesday, May 2nd. The business services provider reported $0.06 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.02 by $0.04. The firm had revenue of $210.30 million during the quarter, compared to the consensus estimate of $206.75 million. Cross Country Healthcare had a net margin of 4.74% and a return on equity of 9.99%. The company’s revenue for the quarter was up 1.3% on a year-over-year basis. During the same quarter last year, the firm earned $0.05 earnings per share.
CCRN has been the subject of a number of research reports. ValuEngine cut shares of Cross Country Healthcare from a “hold” rating to a “sell” rating in a research note on Monday, April 2nd. BidaskClub cut shares of Cross Country Healthcare from a “buy” rating to a “hold” rating in a research note on Tuesday, February 27th. Lake Street Capital reaffirmed a “hold” rating on shares of Cross Country Healthcare in a research note on Friday, March 2nd. BMO Capital Markets reaffirmed an “outperform” rating and issued a $13.00 price objective (down previously from $14.00) on shares of Cross Country Healthcare in a research note on Tuesday, March 6th. Finally, Zacks Investment Research raised shares of Cross Country Healthcare from a “sell” rating to a “hold” rating in a research note on Wednesday, May 9th. Seven research analysts have rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the company. The stock currently has an average rating of “Buy” and a consensus price target of $13.89.
Cross Country Healthcare opened at $12.22 on Thursday, MarketBeat reports. The company has a quick ratio of 2.32, a current ratio of 2.32 and a debt-to-equity ratio of 0.39. Cross Country Healthcare has a 52-week low of $9.07 and a 52-week high of $14.65. The firm has a market cap of $441.89 million, a PE ratio of 20.03, a price-to-earnings-growth ratio of 2.41 and a beta of 0.91.
In other news, CEO William J. Grubbs purchased 10,000 shares of the company’s stock in a transaction on Monday, March 5th. The stock was acquired at an average price of $11.18 per share, with a total value of $111,800.00. Following the transaction, the chief executive officer now directly owns 353,741 shares of the company’s stock, valued at approximately $3,954,824.38. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director W Larry Cash purchased 5,000 shares of the company’s stock in a transaction on Monday, March 5th. The shares were purchased at an average cost of $11.23 per share, with a total value of $56,150.00. Following the transaction, the director now directly owns 113,580 shares in the company, valued at $1,275,503.40. The disclosure for this purchase can be found here. Insiders have acquired a total of 22,500 shares of company stock valued at $253,450 in the last three months. 3.40% of the stock is currently owned by corporate insiders.
Institutional investors and hedge funds have recently made changes to their positions in the business. Koch Industries Inc. purchased a new stake in Cross Country Healthcare during the 1st quarter valued at $117,000. Aperio Group LLC purchased a new stake in Cross Country Healthcare during the 1st quarter valued at $133,000. Barclays PLC boosted its position in Cross Country Healthcare by 118.6% during the 1st quarter. Barclays PLC now owns 12,283 shares of the business services provider’s stock valued at $136,000 after buying an additional 6,665 shares during the period. Renaissance Technologies LLC purchased a new stake in Cross Country Healthcare during the 4th quarter valued at $156,000. Finally, Teacher Retirement System of Texas purchased a new stake in Cross Country Healthcare during the 4th quarter valued at $162,000. 95.62% of the stock is owned by institutional investors and hedge funds.
Cross Country Healthcare Company Profile
Cross Country Healthcare, Inc provides healthcare staffing, recruiting, and workforce solutions in the United States. The company operates in three segments: Nurse and Allied Staffing, Physician Staffing, and Other Human Capital Management Services. The Nurse and Allied Staffing segment offers traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, branch-based local nurses, and allied staffing; short-term staffing of registered nurses, licensed practical nurses, certified nurse assistants, practitioners, pharmacists, and other allied professionals on per diem and short-term assignments; and travel allied professionals on long-term contract assignments.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Cross Country Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cross Country Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.